Thirteen patients had a postoperative haemoglobin between 9.4and 10.5g/dl; they were therefore treated with ferrous sulphate orally for six weeks, after which the mean haemoglobin level was 11.5gldl (range 10.4-12. 6 ). Five patients in the series did not require their autologous blood transfusion.
Three patients suffered complications as a consequence of surgery: one patient lost 750ml in her
Results
No patient was omitted from this series and all patients were seen at review. The mean follow-up was 5months (range 3-12months), and the average length of stay in hospital was 12.9days (range 11-25 days). There were no complications as a result of the patients either giving their own blood or receiving it as an autotransfusion.
The mean peroperative blood loss was 450ml (range 10-850), and postoperative blood loss was 120ml (range 10-750).The mean total blood loss was 570ml (range 250-1010). The mean haemoglobin levels, measured at the stated intervals, were: before elective surgery, when a further unit of blood was taken and the haemoglobin levels repeated.
There were 48 patients, 32women and 16men, with a mean age of 66 years (range 58-78). All patients presented with major joint disease: there were 33 joints with degenerative arthritis, 14 with rheumatoid arthritis and one patient had an advanced haemophilic arthropathy. In addition to their orthopaedic complaint, 22 patients (46%) had a significant medical condition: 6 were known to have ischaemic heart disease, 9 were hypertensive on oral treatment, 5 had chronic obstructive airways disease, one was a haemophiliac and one was a severe colitic being treated with steroids.
The total joint replacements were performed through standard approaches to the hip and knee, 40 being total hip replacements and 8 knee replacements. Peroperative blood loss was recorded by weighing the swabs and meticulous use ofthe sucker. The anaesthetist transfused the patient with the autologous blood, either per-or immediately postoperatively, as was deemed necessary. The wounds were drained routinely using deep and superficial suction drainage. The suction drains were removed between 48 and 96 hours postoperatively, and the volume of blood recorded. Haemoglobin levels were estimated on the third and tenth postoperative days. 
Summary
Autologous blood transfusion is one of the most effective ways of avoiding the need for homologous transfusion and all its associated complications. Since the beginning of 1985, autotransfusions have been used in 48 patients undergoing total joint replacement, without significant complications. Their average haemoglobin level two weeks postoperatively was 11.3 mg{dl. We believe that this is a safe, effective and economical procedure which benefits both patients and medical staff, and its use should be more widespread.
Introduction
Autologous blood transfusion is the recycling of the patient's own blood. The first reported case was by DuncanI in 1886. However, it was not until 1921, when Grant 2 described his experiences, that it became an accepted practice; its use was restricted to those patients with rare blood groups and patients for whom cross-matching was difficult. Homologous blood transfusion was, and has remained, the principal means of blood replacement following operative blood loss.
Autologous blood transfusion has been practised intermittently in a number of specialized centres with favourable results. In orthopaedic surgery, Turner' reported the use of autologous blood in various surgical procedures and, subsequently, Cowell" reported its use in paediatric orthopaedics. Although there have been two previous papers5.6 of autotransfusion in hip surgery, it has either been used in conjunction with homologous blood or patients were excluded for a variety of medical reasons. The purpose of this report is to describe our initial experience in the use of autologous blood transfusion in the management of patients undergoing major joint replacement, thereby avoiding the use of homologous blood.
Materials and method
A protocol was prepared in collaboration with the Department of Haematology. Patients attended hospital for the day, approximately 10-21 days prior to their planned operation, and were clerked by the house officer who also completed all necessary investigations. Provided haemoglobin levels were over 12.0gldl, each patient donated one unit of blood which was labelled with their name, hospital number and date of donation. A special tag was attached to the donation bag carrying a warning that the blood was for autotransfusion only and also carried the signatures of both the patient and the person taking the blood. Patients were formally admitted the day (1) Pre-venesection (2) One day preoperatively (3) Three days postoperatively (4) Ten days.postoperatively 13.0 g/dl (range 12.0-17.0) 12.3 g/dl (range 11.5-16.5) 10.9 g/dl (range 9.4--15.3) 11.3 g/dl (range 9.9-15.5) suction drains and required 2 units of homologous blood -the only patient to require additional homologous blood; one patient developed a superficial wound haematoma that was drained surgically and the wound resutured; and the third patient had an indurated wound that settled on rest and a one-week Course offlucloxacillin 500 mg four times daily.
Discussion
This series supports the finding by Mann et al.' that autologous blood donation prior to elective surgery, even in 'high-risk' patients, is safe and that no patients need be excluded on medical grounds. Furthermore, combined with good surgical and anaesthetic techniques, the use of homologous blood can be avoided. Consequently, all the hazards of homologous blood transfusion are avoided, such as febrile reactions, ABO incompatibility and the transmission of infection, such as hepatitis and the acquired immune deficiency syndrome (AIDS).
The use of autologous blood is also cost-effective. The price ofa unit of homologous blood is estimated at £40 by the Blood Transfusion Service. The material used to collect autologous blood costs £1.
This practice also benefits patients. Not only are they put at ease by avoiding transfusion infections, particularly AIDS s, but they also have the opportunity to meet the nursing staff and become familiar with the ward on their first visit to the hospital to donate a unit of blood, some two weeks before admission for major surgery.
The results of this series are comparable to previous reports5.6. In spite of proven results with autologous transfusion, few have taken advantage of this method by giving blood. This is, in part, due to the excellent Blood Transfusion Service readily making available homologous blood for transfusion; there is also the mistaken belief by some surgeons that the patient will come to surgery in an impaired condition. Surgeons who have involved themselves with autologous blood transfusion have consistently advocated its use? -11. We would support this view.
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In conclusion, autologous blood transfusion is safe, effective and economical, with benefits for both the surgeon and the patient. It is a procedure that can easily be adopted in any UK hospital. In this day and age, where an increased number of expensive tests have to be carried out on homologous blood prior to transfusion, it is surely better to use preventive measures and avoid complications by the use of autogenous blood, where possible.
